Caradigm today announces the appointment of Neal Singh as chief executive.
He replaces Caradigm founder, Michael Simpson, who has left to pursue other business opportunities after leading the company for the past four years.
Singh was previously chief technology officer for Caradigm, where he led the strategic vision and execution of Caradigm’s enterprise portfolio of population health solutions.
A member of Caradigm’s executive leadership team since its inception, he joined the company after spending over a decade as general manager of Microsoft Dynamics. In this role, he led a global team overseeing business strategy, product management and engineering. Throughout his career, he has held multiple executive leadership roles, and is recognised as a thought leader for healthcare technology.
“I am honuored and deeply grateful for the opportunity to lead the exceptional people at Caradigm, who are passionate in their dedication to our customers, and proud to serve the healthcare industry,” he said.
“This is an extraordinary time to be in healthcare and I am thrilled that Caradigm has the ability to innovate – hand-in-hand with our customers – to bring new ideas and solutions to the forefront, as the industry shifts to value-based care.”
His appointment coincides with the rapid growth Caradigm is experiencing through increased market recognition and acceptance of its population health offerings. Recently, the company was rated as a top vendor by Chilmark Research in its inaugural performance report on care management vendors, and received a ConCert Certification from HIMSS for interoperability.
Earlier this month, Caradigm became a wholly-owned affiliate of GE Healthcare. According to Charles Koontz, GE Healthcare chief digital officer: “We have enormous admiration for Neal’s leadership abilities and his track record for software excellence. GE Healthcare is fully committed to supporting Neal and the Caradigm leadership team as they continue to raise the bar for exceeding provider expectations and outcomes in population health.”